Transatlantic Bridges

DWIH Innovation Summit

The German Center for Research and Innovation (DWIH) San Francisco will present the inaugural DWIH Innovation Summit at the Gladstone Institute on February 27, 2025. This event will address the challenge of sharing data across sectors, institutions, and borders, a key question for “Global Health.”  We will welcome experts from Germany, the U.S., and beyond to discuss collaborative approaches to critical health challenges at the intersection of life sciences, AI, and data exchange.

Register

Agenda

12 pm | Registration & Networking Lunch

1 pm | Expert Introduction: Challenges, Opportunities and Visions in the Life Sciences

2:30 pm | Coffee Break & Networking

3:30 pm – 4:30 pm | Parallel Sessions

Session A: Data Exchange in Health – Opportunities and Challenges 

Overview: This session will address the crucial role of data exchange in advancing healthcare, focusing on how secure, efficient data sharing can drive innovation, improve patient outcomes, and enable precision medicine. Participants will discuss best practices, policy frameworks, and technological solutions for enhancing data interoperability across systems and regions. 

  • Juliane Winkelmann, Director of the Institute of Neurogenomics at Helmholtz Munich, Chair of Human Genetics at Technical University Munich  
  • Thomas Lengauer, Lead Bioinformatics at Institute of Virology, University of Cologne 
  • Sharmila Majumdar, UCSF Professor and Vice Chair for Research      
  • Claus Glüer, Professor of Medical Physics, Christian-Albrechts-Universität zu Kiel
  • Ying Lu, Professor of Biomedical Data Science, Stanford University
  • Matthias Haury, Acting Executive Director and COO, Chan-Zuckerberg Imaging Institute 

Moderator:  Paul Schmiedmayer, Lead Artificial Intelligence & Assistant Director of Digital Health, Stanford University  

Session B: Embracing Risk for Breakthrough Innovation in the Life Sciences 

Overview: This session will examine the vital role of risk-taking in achieving transformative advancements in the life sciences. By exploring how public and private sectors manage high-risk, high-reward projects, participants will highlight the potential of daring initiatives to tackle significant health challenges. 

Moderator: Julia Schaletzky, Executive Director, Molecular Therapeutics Initiative, University of California, Berkeley  

Session C: From Treatment to Prevention: The Case for Precision in Public Health 

Objective: Discuss the paradigm shift from personalized medicine to precision public health, focusing on preventive strategies and sustainable healthcare systems. 

  • Katherine Kim, Founder and CEO, Health Tequity 
  • Lothar Wieler, Head of the Digital Global Public Health department at the Hasso Plattner Institute 
  • Frauke Kraas, Professor of Urban and Social Geography at the Institute of Geography, University of Cologne 

4:30 PM – 5:00 PM | Coffee Break

5:00 PM – 6:00 PM | Presentation of Parallel Sessions Results

6:00 PM – 6:30 PM | Closing Remarks and Next Steps

6:30 PM – 8:00 PM | Evening Reception

Event Information

February 27, 2025, 12:00 PM to 6:30 PM

Gladstone Institutes, 1650 Owens St, San Francisco, CA 94158
Organizer(s): DWIH SF, Gladstone Institutes